AMPAR modulator-12

AMPAR modulator-12 是一种可透过血脑屏障的 AMPAR 正向变构调节剂,可降低 NOX-1 表达、增强 AMPAR 介导的电流、促进兴奋性突触后传递并恢复 AMPAR 功能,同时增强兴奋性和抑制性突触传递、减少戒断后外侧缰核的爆发式放电,并产生快速且持久的类抗抑郁作用,因此可用于抑郁症的研究。
产品编号: MS-J82262 CAS No.: 2163787-60-6 分子式: C19H22F2N2O4S2 分子量: 444.52
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
50mg
询价
询价
100mg
询价
询价
250mg
询价
询价

产品描述

AMPAR modulator-12 是一种可透过血脑屏障的 AMPAR 正向变构调节剂,可降低 NOX-1 表达、增强 AMPAR 介导的电流、促进兴奋性突触后传递并恢复 AMPAR 功能,同时增强兴奋性和抑制性突触传递、减少戒断后外侧缰核的爆发式放电,并产生快速且持久的类抗抑郁作用,因此可用于抑郁症的研究。

生物实验数据

生物活性 AMPAR modulator-12 is a blood-brain barrier-permeable positive allosteric modulator of AMPAR that reduces NOX-1 expression, enhances AMPAR-mediated currents, promotes excitatory postsynaptic transmission, and restores AMPAR function, while also enhancing excitatory and inhibitory synaptic transmission, reducing burst firing in the lateral habenula after withdrawal, and producing rapid and sustained antidepressant-like effects, and can therefore be used for the study of depression.
IC50 & Target

AMPA Receptor

 

NOX1

 

体外研究
(In Vitro)

AMPAR modulator-12 (compound K-4) (100 μM; 20-30 min post-treatment) 可增强海马 CA1 锥体神经元中 AMPA 受体介导的诱发兴奋性突触后电流 (EPSCs),使电流幅度较基线水平显著升高。
AMPAR modulator-12 (0.1 μM) 增强桶状皮层 2/3 层锥体神经元中 AMPA 受体介导的诱发兴奋性突触后电流。

体内研究
(In Vivo)

AMPAR modulator-12 (1 mg/kg;静脉注射;7 天) 在 WKY 大鼠中发挥快速的、AMPAR 依赖性的类抗抑郁作用。
AMPAR modulator-12 (1 mg/kg;静脉注射;单次给药) 在慢性束缚应激诱导的抑郁模型大鼠中发挥快速的类抗抑郁作用。

Animal Model: Wistar Kyoto (WKY) rats (male, 5-11 weeks old, congenital depressive phenotype model)
Dosage: 1 mg/kg
Administration: i.v.; single administration; daily for 7 days
Result: Significantly reduced immobility time in the FST, shortened latency to touch and feed in the NSFT, and increased sucrose preference in the SPT at 3 h post-treatment compared to vehicle.
Showed significantly reduced immobility time in the FST on day 8 and day 15 post-withdrawal after 7 days of daily administration; this effect was abolished by co-administration of the AMPAR antagonist GYKI53655.
Significantly increased sucrose preference in the SPT on day 8 and day 15 post-withdrawal, and reduced immobility time in the FST on day 22 post-withdrawal.
Showed no significant differences in locomotor activity compared to vehicle-treated rats.
Significantly restored mEPSC amplitude and increased mEPSC frequency in layer 2/3 pyramidal neurons of the mPFC 30 min post-injection compared to vehicle.
Showed significantly increased mEPSC and mIPSC amplitudes in mPFC pyramidal neurons, and significantly reduced burst firing in lateral habenula (LHb) neurons seven days post-withdrawal from daily administration compared to vehicle controls.
Downregulated Nox1 expression by 2.61-fold compared to ketamine treatment, and by 2.28-fold compared to intact rats in bulk RNA sequencing of mPFC tissue 7 days post-withdrawal.

化学信息

分子量 444.52
分子式 C19H22F2N2O4S2
CAS No. 2163787-60-6

储存&溶解度

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

运输条件 Room temperature in continental US; may vary elsewhere.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础